These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
400 related articles for article (PubMed ID: 19233761)
1. Calcification resistance of procyanidin-treated decellularized porcine aortic valves in vivo. Liu Y; Liu W; Sun G; Wei X; Yi D Heart Surg Forum; 2009 Jan; 12(1):E24-9. PubMed ID: 19233761 [TBL] [Abstract][Full Text] [Related]
2. Crosslinking of decellularized porcine heart valve matrix by procyanidins. Zhai W; Chang J; Lin K; Wang J; Zhao Q; Sun X Biomaterials; 2006 Jul; 27(19):3684-90. PubMed ID: 16513164 [TBL] [Abstract][Full Text] [Related]
3. Kangaroo versus freestyle stentless bioprostheses in a juvenile sheep model: hemodynamic performance and calcification behavior. Neethling WM; Hodge AJ; Glancy R J Card Surg; 2005; 20(1):29-34. PubMed ID: 15673407 [TBL] [Abstract][Full Text] [Related]
5. Amide cross-linking: an alternative to glutaraldehyde fixation. Girardot JM; Girardot MN J Heart Valve Dis; 1996 Sep; 5(5):518-25. PubMed ID: 8894992 [TBL] [Abstract][Full Text] [Related]
6. Preimplant ultrastructure and calcification tendency of various biological aortic valves. Mirzaie M; Meyer T; Schwartz P; Dalichau H J Heart Valve Dis; 2000 Jul; 9(4):576-82. PubMed ID: 10947053 [TBL] [Abstract][Full Text] [Related]
7. The SynerGraft valve: a new acellular (nonglutaraldehyde-fixed) tissue heart valve for autologous recellularization first experimental studies before clinical implantation. O'Brien MF; Goldstein S; Walsh S; Black KS; Elkins R; Clarke D Semin Thorac Cardiovasc Surg; 1999 Oct; 11(4 Suppl 1):194-200. PubMed ID: 10660192 [TBL] [Abstract][Full Text] [Related]
8. Influence of blood contact on the calcification of glutaraldehyde-pretreated porcine aortic valves. Ozaki S; Herijgers P; Flameng W Ann Thorac Cardiovasc Surg; 2003 Aug; 9(4):245-52. PubMed ID: 13129423 [TBL] [Abstract][Full Text] [Related]
9. Glutaraldehyde detoxification in addition to enhanced amine cross-linking dramatically reduces bioprosthetic tissue calcification in the rat model. Weissenstein C; Human P; Bezuidenhout D; Zilla P J Heart Valve Dis; 2000 Mar; 9(2):230-40. PubMed ID: 10772041 [TBL] [Abstract][Full Text] [Related]
10. Mechanisms of the in vivo inhibition of calcification of bioprosthetic porcine aortic valve cusps and aortic wall with triglycidylamine/mercapto bisphosphonate. Rapoport HS; Connolly JM; Fulmer J; Dai N; Murti BH; Gorman RC; Gorman JH; Alferiev I; Levy RJ Biomaterials; 2007 Feb; 28(4):690-9. PubMed ID: 17027944 [TBL] [Abstract][Full Text] [Related]
11. Onset and progression of experimental bioprosthetic heart valve calcification. Schoen FJ; Levy RJ; Nelson AC; Bernhard WF; Nashef A; Hawley M Lab Invest; 1985 May; 52(5):523-32. PubMed ID: 3990244 [TBL] [Abstract][Full Text] [Related]
12. Surface heparin treatment of the decellularized porcine heart valve: Effect on tissue calcification. Yang M; Lin YH; Shi WP; Shi HC; Gu YJ; Shu YS J Biomed Mater Res B Appl Biomater; 2017 Feb; 105(2):400-405. PubMed ID: 26526040 [TBL] [Abstract][Full Text] [Related]
13. Non-Cytotoxic Crosslinkers for Heart Valve Tissue Engineering. Somers P; Roosens A; De Somer F; Cornelissen M; Van Nooten G J Heart Valve Dis; 2015 Jan; 24(1):92-100. PubMed ID: 26182626 [TBL] [Abstract][Full Text] [Related]